Download FREE Report Sample
Download Free sampleOxaprozin (Actirin) is a drug used for the treatment of rheumatoid arthritis, rheumatoid arthritis, osteoarthritis, ankylosis, cervical, shoulder and wrist syndrome, periarthritis of the shoulder, gout, and after trauma and surgery anti-inflammatory analgesia.
Oxaprozin Market contains market size and forecasts of Oxaprozin in global, including the following market information:
Global Oxaprozin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Oxaprozin Market Sales, 2017-2022, 2023-2028, (KG)
Global top five Oxaprozin companies in 2021 (%)
The global Oxaprozin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oxaprozin include Pfizer, Helsinn, Taisho, Ildong, PD-Rx Pharmaceuticals, Therapicon, Neolpharma, Apotex Corporation and Yichang Dongyangguang Changjiang Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Oxaprozin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oxaprozin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Oxaprozin Market Segment Percentages, by Type, 2021 (%)
Tablets
Capsule
Global Oxaprozin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Oxaprozin Market Segment Percentages, by Application, 2021 (%)
Rheumatoid Arthritis
Chronic Infectious Arthritis
Osteoarthritis
Ankylosing Spondylitis
Neck Shoulder Wrist Syndrome
Periarthritis Of Shoulder
Gout
Anti-Inflammatory and Analgesic Effects After Trauma and Surgery
Other
Global Oxaprozin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Oxaprozin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oxaprozin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Oxaprozin revenues share in global market, 2021 (%)
Key companies Oxaprozin sales in global market, 2017-2022 (Estimated), (KG)
Key companies Oxaprozin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Helsinn
Taisho
Ildong
PD-Rx Pharmaceuticals
Therapicon
Neolpharma
Apotex Corporation
Yichang Dongyangguang Changjiang Pharmaceutical
Hubei Baike Hengdi Pharmaceutical
Fuan Pharmaceutical Group
Hubei Baike Hengdi Pharmaceutical
Pfizer
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy